Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Morocco
/
Pharmaceuticals & Biotech
Create a narrative
Societe de Promotion Pharmaceutique du Maghreb Community
CBSE:PRO Community
1
Narratives
written by author
0
Comments
on narratives written by author
3
Fair Values set
on narratives written by author
Create a narrative
Societe de Promotion Pharmaceutique du Maghreb
Popular
Undervalued
Overvalued
Community Investing Ideas
Societe de Promotion Pharmaceutique du Maghreb
AB
Abdouahed
Community Contributor
Promopharm S.A. has shown resilience in the Moroccan pharmaceutical market.
Considerations for the Next Five Years: Product Innovation: The company's recent revenue growth is partly attributed to the success of newly launched products. Continuous innovation and development of new pharmaceuticals will be crucial for sustaining growth. Market Dynamics: The pharmaceutical industry is subject to regulatory changes, competitive pressures, and evolving healthcare needs.
View narrative
د.م914.16
FV
3.0% overvalued
intrinsic discount
18.84%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
11 days ago
author updated this narrative
Your Valuation for
PRO
PRO
Societe de Promotion Pharmaceutique du Maghreb
Your Fair Value
د.م
Current Price
د.م942.00
159.3% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
806m
2015
2018
2021
2024
2025
2027
2030
Revenue د.م805.5m
Earnings د.م56.9m
Advanced
Set Fair Value